Your browser doesn't support javascript.
loading
The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
Russell, David S; Barret, Olivier; Jennings, Danna L; Friedman, Joseph H; Tamagnan, Gilles D; Thomae, David; Alagille, David; Morley, Thomas J; Papin, Caroline; Papapetropoulos, Spyridon; Waterhouse, Rikki N; Seibyl, John P; Marek, Kenneth L.
Afiliação
  • Russell DS; Institute for Neurodegenerative Disorders, New Haven, Connecticut2Molecular NeuroImaging, LLC, New Haven, Connecticut.
  • Barret O; Institute for Neurodegenerative Disorders, New Haven, Connecticut2Molecular NeuroImaging, LLC, New Haven, Connecticut.
  • Jennings DL; Institute for Neurodegenerative Disorders, New Haven, Connecticut2Molecular NeuroImaging, LLC, New Haven, Connecticut.
  • Friedman JH; Department of Neurology, Alpert Medical School of Brown, Providence, Rhode Island.
  • Tamagnan GD; Institute for Neurodegenerative Disorders, New Haven, Connecticut2Molecular NeuroImaging, LLC, New Haven, Connecticut.
  • Thomae D; Institute for Neurodegenerative Disorders, New Haven, Connecticut2Molecular NeuroImaging, LLC, New Haven, Connecticut4currently with Department of Pharmaceutical Sciences, University Hospital Antwerp, Antwerp, Belgium.
  • Alagille D; Institute for Neurodegenerative Disorders, New Haven, Connecticut2Molecular NeuroImaging, LLC, New Haven, Connecticut.
  • Morley TJ; Institute for Neurodegenerative Disorders, New Haven, Connecticut2Molecular NeuroImaging, LLC, New Haven, Connecticut.
  • Papin C; Institute for Neurodegenerative Disorders, New Haven, Connecticut2Molecular NeuroImaging, LLC, New Haven, Connecticut.
  • Papapetropoulos S; Neuroscience Research Unit, Worldwide Research and Development, Pfizer, Inc, Cambridge, Massachusetts.
  • Waterhouse RN; Neuroscience Research Unit, Worldwide Research and Development, Pfizer, Inc, Cambridge, Massachusetts.
  • Seibyl JP; Institute for Neurodegenerative Disorders, New Haven, Connecticut2Molecular NeuroImaging, LLC, New Haven, Connecticut.
  • Marek KL; Institute for Neurodegenerative Disorders, New Haven, Connecticut2Molecular NeuroImaging, LLC, New Haven, Connecticut.
JAMA Neurol ; 71(12): 1520-8, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25322077
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Huntington / Diester Fosfórico Hidrolases / Corpo Estriado / Tomografia por Emissão de Pósitrons Tipo de estudo: Diagnostic_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2014 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Huntington / Diester Fosfórico Hidrolases / Corpo Estriado / Tomografia por Emissão de Pósitrons Tipo de estudo: Diagnostic_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2014 Tipo de documento: Article País de publicação: Estados Unidos